Top

Published in:

Open Access 01-12-2020 | Hepatitis B | Research article

Prevalence and trends of transfusion transmissible infections among blood donors in the State of Qatar, 2013–2017

Authors: Mohamed Aabdien, Nagah Selim, Sayed Himatt, Saloua Hmissi, Zeyd Merenkov, Noora AlKubaisi, Manar E. Abdel-Rahman, Abdelatif Abdelmola, Shadi Khelfa, Elmoubasher Farag, Hamad E. Al-Romaihi, Mohamed Al-Thani, Moutaz Derbala, Saad Al-Kaabi

Published in: BMC Infectious Diseases | Issue 1/2020

Abstract

Background

Millions of lives around the world are being saved annually through blood transfusion. However, blood transfusion is among the essential vehicles for transmitting infections. The overall prevalence of Transfusion Transmissible Infections among blood donors differs around the world, reflecting the variation in the prevalence of these infections. This study aims to assess the prevalence and trends of Transfusion Transmissible Infections among blood donors in Qatar.

Methods

This is a cross-sectional study utilizing donation records of 5 years from January 2013 to December 2017. We included in the study results for all screening and confirmatory tests for Hepatitis B Virus, Hepatitis C Virus, Human T-lymphotropic Virus-I/II, Syphilis and Malaria.

Results

Among the 190,509 donations received at the donation centre during the study period, about 91% of donations were received from males and 9% from females. The overall positivity rate for all tests was 1.87, 2.23, 1.78, 2.31, 2.67% for the years 2013 through 2017, with an increasing yearly trend by 6% each year. The overall positivity rates for Hepatitis C Virus, Human T-lymphotropic Virus-I/II, Hepatitis B Virus, Syphilis and Malaria (2013–2017) were 0.60, 0.18, 0.30, 0.43 and 0.20%, respectively.

Conclusion

The overall positivity rate of all tests combined for the Transfusion Transmissible Infections demonstrated a gradually increasing trend from 2013 to 2017. However, the trend for each infection (Hepatitis C Virus, Hepatitis B Virus, Syphilis and Malaria) was fluctuating except for Human T-lymphotropic Virus-I/II, which was increasing. Supporting the development of effective prevention and control strategies requires further comprehensive investigations for better estimation of the burden of these infections.

International Society of Blood Transfusion (ISBT). Global Blood Safety [Internet]. [cited 2018 Mar 5]. Available from: http://www.isbtweb.org/working-parties/global-blood-safety/.

World Health Organization (WHO). Processing of donated blood [Internet]. Blood transfusion safety. [cited 2018 Mar 19]. Available from: http://www.who.int/bloodsafety/processing/en/.

Centers for Disease Control and Prevention (CDC). Transfusion-transmitted Infections. [Internet]. 2011 [cited 2018 Mar 19]. Available from: https://www.cdc.gov/bloodsafety/tools/investigation-toolkit.html.

International Society of Blood Transfusion (ISBT). Transfusion Transmitted Infectious Diseases [Internet]. [cited 2018 Mar 5]. Available from: http://www.isbtweb.org/working-parties/transfusion-transmitted-infectious-diseases/.

World Health Organization (WHO). Blood safety and availability [Internet]: WHO; 2017. [cited 2018 Mar 5]. Available from: http://www.who.int/mediacentre/factsheets/fs279/en/.

World Health Organization (WHO). New hepatitis data highlight need for urgent global response [Internet]: WHO; 2017. [cited 2018 Mar 21]. Available from: http://www.who.int/mediacentre/news/releases/2017/global-hepatitis-report/en/.

Gessain A, Cassar O, European Centre for Disease Prevention and Control. Geographical distribution of areas with a high prevalence of HTLV-1 infection. [Internet]. Stockholm: ECDC; 2015. [cited 2019 Apr 10]. Available from: http://bookshop.europa.eu/uri?target=EUB:NOTICE:TQ0215177:EN:HTML.

Ahmadpour E, Foroutan-Rad M, Majidiani H, Moghaddam SM, Hatam-Nahavandi K, Hosseini S-A, et al. Transfusion-Transmitted Malaria: A Systematic Review and Meta-analysis. Open Forum Infect Dis. 2019;6(7):ofz283 [cited 2020 Jan 8]. Available from: https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofz283/5514070.PubMedPubMedCentralCrossRef

World Health Organization (WHO). Global database on blood safety [Internet]: WHO; 2018. [cited 2018 Mar 26]. Available from: http://www.who.int/bloodsafety/global_database/en/.

10.

World Health Organization (WHO). A guide to establishing a national haemovigilance system [Internet]. Geneva: WHO; 2016. [cited 2018 Mar 26]. Available from: http://apps.who.int/iris/bitstream/handle/10665/250233/9789241549844-eng.pdf;jsessionid=1E9DF08707F3F5A5CC1AE39588EA87E7?sequence=1.

11.

World Health Organization (WHO). 10 facts on blood transfusion [Internet]: WHO; 2017. [cited 2018 Mar 21]. Available from: http://www.who.int/features/factfiles/blood_transfusion/en/.

12.

Sarah YAEGA, Sabry AEGAEHES, Maryam AA-S. Seropositivity of TTIs among blood donors in Hail, Saudi Arabia, from 2014 to 2015. Asian Pac J Trop Dis. 2016;6(2):141–6 [cited 2018 Dec 25]. Available from: https://doi.org/10.1016/S2222-1808(15)61000-3.CrossRef

13.

Alcantara JC, Alenezi FKM, Ali OHH. Seroprevalence and trends of markers of transfusion transmissible infections among blood donors: a 3-year hospital based-study. Int J Community Med Public Health. 2018;5(12):5031–5 [cited 2018 Dec 25]. Available from: https://doi.org/10.18203/2394-6040.ijcmph20184773.CrossRef

14.

Bani M, Giussani B. Gender differences in giving blood: a review of the literature. Blood Transfus. 2010;8(4):278–87 [cited 2019 Jan 22]. Available from: https://doi.org/10.2450/2010.0156-09.PubMedPubMedCentral

15.

Xu T, Yi Z, Luo J, Yu H, Fan Y, Lu H, et al. Prevalence and trends of transfusion-transmittable infections among blood donors in Southwest China. J Public Health, Available from. 2018; [cited 2018 Dec 25]. https://doi.org/10.1093/pubmed/fdx189.

16.

Wairimu KM, Herbert K, John M. Prevalence of transfusion transmissible infections Among Blood donated at Nyeri satellite transfusion Centre in Kenya. IOSR J Pharm. 2016;6(2):20–30 Available from: http://iosrphr.org/papers/v6i2/D0622030.pdf.

17.

Negi G, Gaur DS. Trends of Transfusion Transmissible Diseases Among Blood Donors at Uttarakhand, India. Indian J Community Med. 2014;39(3):183–6 [cited 2018 Dec 26]. Available from: https://doi.org/10.4103/0970-0218.137161.PubMedPubMedCentralCrossRef

18.

Arshad A, Borhany M, Anwar N, Naseer I, Ansari R, Boota S, et al. Prevalence of transfusion transmissible infections in blood donors of Pakistan. BMC Hematol. 2016;16 [cited 2018 Mar 25]. Available from: https://doi.org/10.1186/s12878-016-0068-2.

19.

Almaiman AA. Evaluation of Blood Donors and transfusion transmitted infections and their association with ABO and Rh Blood groups in Unaizah, Saudi Arabia: A retrospective study. Int J Med Res Health Sci. 2018;7(3):143–50 Available from: https://www.ijmrhs.com/medical-research/evaluation-of-blood-donors-and-transfusion-transmitted-infections-and-their-association-with-abo-and-rh-blood-groups-in-.pdf.

20.

Keshvari M, Sharafi H, Alavian SM, Mehrabadi H, Zolfaghari S. Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013. Transfus Apher Sci. 2015;53(1):38–47 [cited 2019 Mar 29]. Available from: https://doi.org/10.1016/j.transci.2015.03.003.PubMedCrossRef

21.

El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J. 2004;25(1):26–33 Available from: https://www.ncbi.nlm.nih.gov/pubmed/14758374.PubMed

22.

Farshadpour F, Taherkhani R, Tajbakhsh S, Gholizadeh Tangestani M, Hajiani G, Sharifi N, et al. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study. PLoS One. 2016;11(6) [cited 2018 Dec 26]. Available from: https://doi.org/10.1371/journal.pone.0157615.

23.

Ji Z-H, Li C-Y, Lv Y-G, Cao W, Chen Y-Z, Chen X-P, et al. The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi’an, China between 1999 and 2009. Int J Infect Dis. 2013;17(4):e259–62 [cited 2018 Mar 24]. Available from: https://doi.org/10.1016/j.ijid.2012.10.006.PubMedCrossRef

24.

de Almeida NC, McFarland W, Murphy EL, Chen S, Nogueira FAH, Mendrone A, et al. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria. Transfusion. 2007;47(4):608–14 Available from: https://doi.org/10.1111/j.1537-2995.2007.01161.x.CrossRef

25.

Nébié KY, Olinger CM, Kafando E, Dahourou H, Diallo S, Kientega Y, et al. Lack of knowledge among blood donors in Burkina Faso (West Africa); potential obstacle to transfusion security. Transfus Clin Biol. 2007;14(5):446–52 Available from: https://doi.org/10.1016/j.tracli.2007.12.005.PubMedCrossRef

26.

Goncalez TT, Sabino EC, Murphy EL, Chen S, Chamone DAF, McFarland W. Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil. Vox Sang. 2006;90(3):170–6 Available from: https://doi.org/10.1111/j.1423-0410.2006.00743.x.PubMedCrossRef

27.

Elbjeirami W, Al-Jedani H, Arsheed N, Elnagdi N, Abou Eisha H, Abdulwahab A, et al. Prevalence and Trends of Common Transfusion Transmitted Infections Using Serological and Nucleic Acid Markers in Saudi Blood Donors. J Blood Disord Transfus. 2015;06(03) [cited 2018 Dec 26]. Available from: https://doi.org/10.4172/2155-9864.1000280.

28.

Omran D, Hussein E, Nagib M. Safety of Blood Transfusion: An Egyptian Study. J Infect Dis Ther. 2014;02(01) [cited 2018 Dec 28]. Available from: http://esciencecentral.org/journals/safety-of-blood-transfusion-an-egyptian-study-2332-0877.1000124.php?aid=22486.

29.

Sharma DC, Rai S, Bharat S, Iyenger S, Gupta S, Sao S, et al. Transfusion Transmissible Infections among Blood Donors at the Blood Bank of Medical College of Gwalior: A 5 Year Study. Int Blood Res Rev. 2014;2(5):235–46 [cited 2018 Dec 28]. Available from: http://www.sciencedomain.org/abstract/4930.CrossRef

30.

Buseri FI, Muhibi MA, Jeremiah ZA. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfus. 2009;7(4):293–9 [cited 2020 Jan 14]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782806/.PubMedPubMedCentral

31.

Babanejad M, Izadi N, Najafi F, Alavian SM. The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon. 2016;16(3) [cited 2019 Apr 8]. Available from: https://doi.org/10.5812/hepatmon.35664.

32.

Al-Romaihi H, Al-Masri H, Shawky S, Al Thani M, Al Awaidy S, Janahi MA, et al. Assessment of hepatitis B immunization programme among school students in Qatar. EMHJ. 2018;24(08):736–44 [cited 2019 Apr 8]. Available from: https://doi.org/10.26719/2018.24.8.736.PubMed

33.

Ghaderi-Zefrehi H, Sharafi H, Sadeghi F, Gholami-Fesharaki M, Farasat A, Jahanpeyma F, et al. Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis. Iran Red Crescent Med J. 2017;19(12) [cited 2019 Apr 8]. Available from: https://doi.org/10.5812/ircmj.58045.

34.

Bawazir A, AlGusheri F, Jradi H, AlBalwi M, Abdel-Gader A-G. Hepatitis C virus genotypes in Saudi Arabia: a future prediction and laboratory profile. Virol J. 2017;14 [cited 2019 Apr 8]. Available from: https://doi.org/10.1186/s12985-017-0873-7.

35.

World Health Organization (WHO). Screening donated blood for transfusion-transmissible infections: recommendations. Geneva: WHO; 2010.

36.

Murphy EL. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety. Transfus Clin Biol. 2016;23(1):13–9 [cited 2018 Dec 30]. Available from: https://doi.org/10.1016/j.tracli.2015.12.001.PubMedPubMedCentralCrossRef

37.

Alaidarous M, Choudhary RK, Waly MI, Mir S, Bin Dukhyil A, Banawas SS, et al. The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia. J Infect Public Health. 2018;11(5):702–6 Available from: https://doi.org/10.1016/j.jiph.2018.04.008.PubMedCrossRef

38.

Saeed AA, Al Rasheed AM, Al Nasser I, Al Onaizi M, Al Kahtani S, Dubois L. Malaria Screening of Blood Donors in Saudi Arabia. Ann Saudi Med. 2002 ;22(5–6):329–332. [cited 2019 Apr 12]. Available from: https://doi.org/10.5144/0256-4947.2002.329.

39.

World Health Organization (WHO). Global status report on blood safety and availability, 2016. Geneva: WHO; 2017. [cited 2018 Mar 15]. Available from: http://apps.who.int/iris/bitstream/10665/254987/1/9789241565431-eng.pdf.

40.

Al-Sadeq DW, Taleb SA, Zaied RE, Fahad SM, Smatti MK, Rizeq BR, et al. Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update. Pathogens. 2019;8(2):63 [cited 2020 Jan 15]. Available from: https://www.mdpi.com/2076-0817/8/2/63.PubMedCentralCrossRef

41.

Al-Absi ES, Al- Sadeq DW, Younis MH, Yassine HM, Abdalla OM, Mesleh AG, et al. Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors. J Med Microbiol. 2018;67(9):1302–9 [cited 2020 Jan 15]. Available from: https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.000807.PubMedCrossRef

Title: Prevalence and trends of transfusion transmissible infections among blood donors in the State of Qatar, 2013–2017
Authors: Mohamed Aabdien
Nagah Selim
Sayed Himatt
Saloua Hmissi
Zeyd Merenkov
Noora AlKubaisi
Manar E. Abdel-Rahman
Abdelatif Abdelmola
Shadi Khelfa
Elmoubasher Farag
Hamad E. Al-Romaihi
Mohamed Al-Thani
Moutaz Derbala
Saad Al-Kaabi
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Hepatitis B
Syphilis
Malaria
Hepatitis C
Published in: BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-020-05344-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2020

Implementation of the FilmArray ME panel in laboratory routine using a simple sample selection strategy for diagnosis of meningitis and encephalitis

Sex differences in campylobacteriosis incidence rates at different ages - a seven country, multi-year, meta-analysis. A potential mechanism for the infection

Tuberculosis active case-finding interventions and approaches for prisoners in sub-Saharan Africa: a systematic scoping review

Hepatitis E virus outbreak associated with rainfall in the Central African Republic in 2008-2009

Sarcoidosis with cryptococcal infection apparently engaging only immune-privileged body compartments: a case report

The diagnostic utility of the “Thwaites’ system” and “lancet consensus scoring system” in tuberculous vs. non-tuberculous subacute and chronic meningitis: multicenter analysis of 395 adult patients

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage